It is not known whether it is safe to consume alcohol with Ertinib 150. Please consult your doctor.
CONSULT YOUR DOCTOR
Ertinib 150 is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please cons...
... Show more
CONSULT YOUR DOCTOR
Ertinib 150 is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
CONSULT YOUR DOCTOR
It is not known whether Ertinib 150 alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
SAFE IF PRESCRIBED
Ertinib 150 is safe to use in patients with kidney disease. No dose adjustment of Ertinib 150 is recommended.
Use of this medicine is not advised in patients with severe kidney disease.
CAUTION
Ertinib 150 should be used with caution in patients with liver disease. Dose adjustment of Ertinib 150 may be needed. Please consult your doctor.
Limited information is available on the use of Ertinib 150 in these patients. No dose adjustment is reco...
... Show more
Medicine Overview of Ertinib 150mg Tablet
Introduction
Ertinib 150 is used in the treatment of non-small cell lung cancer and pancreatic cancer.
Ertinib 150 should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor...
... Show more
Uses of Ertinib 150
Non-small cell lung cancer
Pancreatic cancer
Side effects of Ertinib 150
Common
Abdominal pain
Bone pain
Breathlessness
Constipation
Cough
Diarrhea
Fatigue
Fever
Infection
Muscle pain
Nausea
Rash
Stomatitis (Inflammation of the mouth)
Vomiting
Weight loss
How to use Ertinib 150
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ertinib 150 is to be taken empty stomach.
How Ertinib 150 works
Ertinib 150 is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer sign...
... Show more
What if you forget to take Ertinib 150?
If you miss a dose of Ertinib 150, skip it and continue with your normal schedule. Do not double the dose.
Quick Tips
Ertinib 150 helps treat non-small cell lung cancer that is locally advanced, or has spread to other areas of the body.
It should be taken 1 hour before or 2 hours after the meal.
Diarrhea may occur as a side effect. Drink plenty of fluids and inform your doctor if it doesn't stop or if you find blood in your stools.
Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
It makes your skin sensitive towards sunlight. Apply sunscreen or wear protective clothing while going out.
It is advisable to avoid smoking while taking this medicine, as it makes the drug ineffective and requires dose adjustment.
Do not take it with medication lowering the stomach acid (such as antacids, H2 blockers including ranitidine), as it may affect the working ...
... Show more
Inform your doctor if you develop ulceration in your mouth, changes in your vision or if you experience a worsening cough, shortness of brea...
... Show more
Your doctor may want you to have regular blood tests to monitor your liver function while you are having treatment with this medicine.
Do not take this medicine if you are pregnant, planning to conceive or breastfeeding.
Brief Description
Indication
Small cell lung cancer, Pancreatic cancer
Administration
Should be taken on an empty stomach. Take on an empty stomach at least 1 hr before or 2 hr after meals.
Adult Dose
Oral
Locally advanced or metastatic non-small cell lung carcinoma
Adult: 150 mg once daily until disease progression or unacceptable toxicity. Reduc...
... Show more
Child Dose
Safety and efficacy not established
Contraindication
Hypersensitivity.
Mode of Action
Erlotinib is an epidermal growth factor receptor/human epidermal growth factor receptor type 1 (EGFR/HER1) tyrosine kinase inhibitor. It reversibly in...
... Show more
Precaution
Pregnancy and lactation. Interrupt Erlotinib therapy if patient develops unexplained pulmonary symptoms e.g. dyspnoea, cough, fever; discontinue thera...
Pregnancy
Based on animal data and its mechanism of action, erlotinib can cause fetal harm when administered to a pregnant woman
Advise females of r...
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.